Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja von Heydebreck

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Histopathology|May 13, 2010
Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosisFlorian Haller, Abbas Agaimy, Silke Cameron, et al.
Cancer Genetics and Cytogenetics|March 18, 2005
Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymusRalf J Rieker, Roland Penzel, Sebastian Aulmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 2007
Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumorsFlorian Haller, Nicole Happel, Hans-Jürgen Schulten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumorsFlorian Haller, Bastian Gunawan, Anja von Heydebreck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancerJean-Yves Douillard, Robert Pirker, Kenneth J O'Byrne, et al.
The Journal of Pathology|April 20, 2004
Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumoursBastian Gunawan, Hans-Jürgen Schulten, Anja von Heydebreck, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 31, 2021
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumabNadia Terranova, Jonathan French, Haiqing Dai, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
The Journal of Experimental Medicine|September 17, 2008
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysisVerena Brune, Enrico Tiacci, Ines Pfeil, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Histopathology|May 13, 2010
Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosisFlorian Haller, Abbas Agaimy, Silke Cameron, et al.
Cancer Genetics and Cytogenetics|March 18, 2005
Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymusRalf J Rieker, Roland Penzel, Sebastian Aulmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 2007
Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumorsFlorian Haller, Nicole Happel, Hans-Jürgen Schulten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumorsFlorian Haller, Bastian Gunawan, Anja von Heydebreck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancerJean-Yves Douillard, Robert Pirker, Kenneth J O'Byrne, et al.
The Journal of Pathology|April 20, 2004
Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumoursBastian Gunawan, Hans-Jürgen Schulten, Anja von Heydebreck, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 31, 2021
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumabNadia Terranova, Jonathan French, Haiqing Dai, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
The Journal of Experimental Medicine|September 17, 2008
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysisVerena Brune, Enrico Tiacci, Ines Pfeil, et al.
Pageof 4